Veritas Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-20
Closed -$4K 68
2018
Q2
$4K Hold
20
﹤0.01% 59
2018
Q1
$3K Sell
20
-500
-96% -$91.8K ﹤0.01% 62
2017
Q4
$90K Hold
520
0.01% 57
2017
Q3
$97K Hold
520
0.01% 56
2017
Q2
$90K Hold
520
0.01% 57
2017
Q1
$85K Hold
520
0.01% 62
2016
Q4
$76K Buy
+520
New +$78.3K 0.01% 65

Other funds holding AMGN

Veritas Investment Management's AMGN Position: Q3 2018 in Review

Veritas Investment Management sold out of Amgen (AMGN) in Q3 2018, closing a stake of 20 shares — an estimated $4K sold.

Veritas Investment Management first reported a position in AMGN in Q4 2016 and held it in 7 quarters. The position peaked at $97K in Q3 2017. 1,796 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.

  • Veritas Investment Management reported no remaining Amgen position as of Q3 2018 after selling out during the quarter.
  • Veritas Investment Management sold 20 Amgen shares in Q3 2018, an estimated $4K.
  • Veritas Investment Management first reported a position in Amgen in Q4 2016 and held it in 7 quarters.
  • Veritas Investment Management's Amgen position peaked at $97K in Q3 2017.
  • 1,796 funds tracked by Wall St. Rank held Amgen as of Q3 2018.

Based on Veritas Investment Management's 13F filing for Q3 2018, filed 7 Nov 2018.